Pre-exposure Prophylaxis (PrEP) at Home

NACompletedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

April 15, 2023

Study Completion Date

April 15, 2023

Conditions
HIV/AIDS
Interventions
BEHAVIORAL

PrEP@Home System

"The PrEP@Home system includes a home care kit mailed quarterly to participants. The kit has components for self-collection of urine, rectal and pharyngeal swabs, microtube blood collection, and materials for return shipping. Biological tests routinely performed at PrEP follow-up (FU) visits will be done on the specimens. At months 6 and 12, the kit will include materials to assess for protective levels of emtricitabine triphosphate (FTC-TP).~The system includes a study app through which participants may track the mailing of home testing kits, access quarterly surveys, and communicate with study clinicians. The surveys will include domains that physicians assess at PrEP care quarterly FU visits (sexual risk, illicit substance use, PrEP adherence, side effects).~Study Clinicians will review Lab and survey results and if the results show no contraindications for PrEP continuation, the clinician may renew a participant's PrEP prescription. Telemedicine visits will be scheduled as needed."

OTHER

Standard of Care

Control participants will receive clinic-based PrEP follow-up. After the baseline assessment, control participants will receive active linkage to standard, clinic-based PrEP care for their next PrEP care follow-up visit. Participants will also download the control version of the study app, which will contain only research elements pertinent to their participation in the control arm of the study including quarterly surveys. At months 6 and 12, control arm participants will be sent materials for DBS self-collection and return shipping to allow for measurement of the study outcome, emtricitabine triphosphate (FTC-TP).

Trial Locations (5)

30322

Emory University, PRISM Health, Atlanta

39202

Open Arms Health Care Center, Jackson

44109

MetroHealth, Cleveland

63110

Washington University AIDS Clinical Trial Unit, St Louis

02215

The Fenway Institute, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER

NCT03569813 - Pre-exposure Prophylaxis (PrEP) at Home | Biotech Hunter | Biotech Hunter